Genelux Corporation (GNLX)
Nasdaq: GNLX · Pharmaceutical Preparations · Westlake Village, CA · filing with the SEC since 2003
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 19, 2026 | Mar 28, 2025 | Mar 29, 2024 | Mar 29, 2023 |
| Revenue | 8 | 8 | 170 | 11,068 |
| Research and development | 19,851 | 18,998 | 12,767 | 9,078 |
| General and administrative | 13,371 | 12,706 | 11,568 | 5,003 |
| Total operating expenses | 33,222 | 31,704 | 24,335 | 14,081 |
| Operating income | -33,214 | -31,696 | -24,165 | -3,013 |
| Interest expense | · | · | 173 | · |
| Interest and investment income | 711 | 700 | 182r | · |
| Total non-operating income (expense) | 1,069 | 1,827 | -4,132 | -1,094 |
| Income tax expense | · | · | · | 1,100 |
| Net income | -32,145 | -29,869 | -28,297 | -5,207 |
| Earnings per share, basic | -0.86 | -0.95 | -1.16 | -0.57 |
| Earnings per share, diluted | -0.86 | -0.95 | -1.16 | -0.57 |
| Weighted average shares, basic | 37,176,527 | 31,450,727 | 31,450,727r | 9,116,489 |
| Weighted average shares, diluted | 37,176,527 | 31,450,727 | 24,429,278 | 9,116,489 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding